SUN PHARMACEUTICAL IND L
Long
Mis à jour

SUNPHARMA (Trade the Trend) - Bullish

217
SUNPHARMA - Sun Pharmaceutical Industries Ltd. SUNPHARMA

After Q4 Results we saw a good sell-off in Sunpharma, yet the price hardly moved much

Shanghvi stated "Our India business continues to grow faster than the market, leading to an increase in market share. We continue to focus on expanding our global specialty business, growing all our businesses, and improving operational efficiencies," stated.

The company said its board has proposed a final dividend of Rs 3 per share for FY22.

One can plan a long position between 835 to 840 with a strict SL of Rs 825 for short term trading (01 to 02 weeks) and SL if the price moves below 825 (Daily candle close) for long term swing trading (greater than 2 weeks)

Short Term targets are up to - 886
Long Term Target is up to - 929

Risk Reward for this trade is very good

#Learn&earn #Wealth #Editor's Choice #trending #Weathmagnet candlestick analysis, candlestick stock pattern

Do Support by Liking and Commenting on our Post as it motivates us to post more such ideas

The chart is for study purposes only!!
Kindly consult your Financial Advisor before investing any money
Transaction en cours
Buy for long-term triggered at Rs 835 and now I have an Average of 832
Transaction en cours
Short swing trade SL Hit
Note
But I am into long-term Swing, my Stop loss is candle closing below 125 today
Note
My Trade is still active as the Daily candle did not close below 125

Guys Need your support Do Like and comment on my Post
Transaction en cours
An update for people following this trade, The trade is still active as the closing for June 14 was 825.05
Trade fermée: ordre d’arrêt atteint
SL Hit

Clause de non-responsabilité

Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.